E-LIB Suche - Ergebnisse für: de Stanchina, Elisa

1

Zurletrectinib is a next-generation TRK inhibitor with stro..:

Roa, Paola ; Foglizzo, Valentina ; Harada, Guilherme...
British Journal of Cancer. , 2024

Link: https://doi.org/10.1038/..

2

Methylation of the chromatin modifier KMT2D by SMYD2 contri..:

Blawski, Ryan ; Vokshi, Bujamin H. ; Guo, Xinyu...
Cell Reports. 43 (2024) 5 - p. 114174 , 2024

Link: https://doi.org/10.1016/..

3

Combined inhibition of KRASG12C and mTORC1 kinase is synerg..:

Kitai, Hidenori ; Choi, Philip H. ; Yang, Yu C....
Nature Communications. 15 (2024) 1 - p. , 2024

Link: https://doi.org/10.1038/..

4

Heterodimerization of T cell engaging bispecific antibodies..:

Long, Alan W ; Xu, Hong ; Santich, Brian H...
Journal of Hematology & Oncology. 17 (2024) 1 - p. , 2024

Link: https://doi.org/10.1186/..

5

Preclinical Evaluation of Chimeric Antigen Receptor-Modifie..:

Shahid, Sanam ; Kontopoulos, Theodota ; luduec, Jean-benoit Le...
Transplantation and Cellular Therapy. 30 (2024) 2 - p. S176-S177 , 2024

Link: https://doi.org/10.1016/..

6

Vepafestinib is a pharmacologically advanced RET-selective ..:

Miyazaki, Isao ; Odintsov, Igor ; Ishida, Keiji...
Nature Cancer. 4 (2023) 9 - p. 1345-1361 , 2023

Link: https://doi.org/10.1038/..

7

Inducible expression of interleukin-12 augments the efficac..:

Yang, Yanping ; Yang, Huan ; Alcaina, Yago...
Nature Communications. 14 (2023) 1 - p. , 2023

Link: https://doi.org/10.1038/..

8

STING inhibits the reactivation of dormant metastasis in lu..:

Hu, Jing ; Sánchez-Rivera, Francisco J. ; Wang, Zhenghan...
Nature. 616 (2023) 7958 - p. 806-813 , 2023

Link: https://doi.org/10.1038/..

9

Pan-KRAS inhibitor disables oncogenic signalling and tumour..:

Kim, Dongsung ; Herdeis, Lorenz ; Rudolph, Dorothea...
Nature. 619 (2023) 7968 - p. 160-166 , 2023

Link: https://doi.org/10.1038/..

10

Synthetic lethality of drug-induced polyploidy and BCL-2 in..:

Portelinha, Ana ; da Silva Ferreira, Mariana ; Erazo, Tatiana...
Nature Communications. 14 (2023) 1 - p. , 2023

Link: https://doi.org/10.1038/..

11

Antitumor activity of the PI3K δ-sparing inhibitor MEN1611 ..:

Fiascarelli, Alessio ; Merlino, Giuseppe ; Capano, Stefania...
Breast Cancer Research and Treatment. 199 (2023) 1 - p. 13-23 , 2023

Link: https://doi.org/10.1007/..

12

Targeting NFE2L2/KEAP1 Mutations in Advanced NSCLC With the..:

Paik, Paul K. ; Fan, Pang-Dian ; Qeriqi, Besnik...
Journal of Thoracic Oncology. 18 (2023) 4 - p. 516-526 , 2023

Link: https://doi.org/10.1016/..

13

Conserved transcriptional connectivity of regulatory T cell..:

Glasner, Ariella ; Rose, Samuel A. ; Sharma, Roshan...
Nature Immunology. 24 (2023) 6 - p. 1020-1035 , 2023

Link: https://doi.org/10.1038/..

14

A Druggable FOXA1-Glucocorticoid Receptor Transcriptional A..:

Dorso, M. ; Patel, Payal T. ; Pankov, Aleksandr...
Cancer Research Communications. 3 (2023) 9 - p. 1788-1799 , 2023

Link: https://doi.org/10.1158/..

15

Author Correction: Vepafestinib is a pharmacologically adva..:

Miyazaki, Isao ; Odintsov, Igor ; Ishida, Keiji...
Nature Cancer. 4 (2023) 10 - p. 1526-1526 , 2023

Link: https://doi.org/10.1038/..